Marcus Brent Fields v. Pfizer Inc., et al.

U-S.C f'Cor-Hvd 'X.rvj CJvfcu.U * lU4U I diV-JS^ yC$-(KC ' So-UMiM Q/S'i-of iw¥. k^-CV-b&gS ;. QUEST10N(S)-RRESENTED :___________ _ T\tL(KS V P£«'zxt Ia.c • 6+ tU. - Mb£r4 Bo^vrU CEbi Oru, Wt/^Srv<^A euM^ l°l X/weAflf • Katahn KacJKo , p>h-N-7eck .Bfr -cke/wfs+ ’ 7z>V>a <u8 iSclW*)^ t ?hy$}aty ' ' U^OiC S&.V i A - Bio- '___________ _ _______ . ________________________ ^. CT) ^(M'-Ca/A^aA S Vva&vj -there C&v‘‘ A - U o4 CpuU - cause More sever <?r Hear4 Aa/wcujt"- body cAom^c LSpeC/aV^ rffi®gjOtasA CIMOa^vIsV !rt (VnC/l^lK- T £) C< A 9-fiZer IaC. OaZb\d<Mv%i Kaovj A-K-Cy brt?Ke 44-xX Lccvo t)y LX'V&r'HoA , k^b655l£n ' frnA breoJK<A3 W,S> Yf^U4>iry - Gjv>k/a^ AC-f cybercri'r\e a/\d Z£rAe<|«H L-ovj Y/xA^rA^AAo^ v^VA/V/'aaS rvo-V CorAptCc^fnEj A'VvCDvUj'K 9 KoU'A'vAcocUt a| Trtul Plfv^c‘s desj S-'X'7? on b I a(/lcy - i ftij <Ws Pr»-f;+ su’rfAMj- ©ra e&'ecA ■vho'r NxorJ-cUrUr ;« U« S<rf«y (W»AW nxoce © W +\mkx CmI^\ Pu4>/<.' Consul SA-W^U AwW«lJ»nM, P 04^ £of a be4Uc t n^rXeA £/Wce r-'vH M HKt t C^Vlr - Pr.^uT^Y'1’- J S/3it e^’ ' ASi S) - tVA POz-erlnC ft^AiuAs Wik- Drug reject La^5 - V('oU(i'0AS- r\Mu- - S^byis - P^IM/^s - S> ’ 0<A pf/zer tie/cnAAnVS break 'SeceriUeS EK.ckcL/\y evrn /va^S/m (AA/Wj i FeAun\ Lov^ ' ViSuAf^s ^rVvks- t Sovao-U^^ » t Ot&5 © (KA PCttr (We/U^-H Wk -- VrU-4 T<«<k c^^Moa ru»«s- sc^a.'^s - hUM- W Ch DiJ Pfw Cef^aW (Kal< Owr U,A.CjMv5|(4wfnM».l -<UWi - ALcuajS ________________ _______ - —.— -------------------------------------- 't JXcAfcU YTt SclW^a "X ' Sech^^ * fkcAfcR. \ \f S^P^a I